MIR-122 DYSREGULATION IN SIRNA-TREATED IN VITRO CELL MODEL OF HUNTINGTON'S DISEASE

dc.contributor.authorTunali, Nagehan Ersoy
dc.contributor.authorKeske, Ezgi
dc.date.accessioned2025-05-10T19:40:41Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionPlenary Meeting of the European-Huntington's-Disease-Network (EHDN) -- SEP 16-18, 2022 -- Bologna, ITALY
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Huntingtons Dis Network
dc.identifier.doi10.1136/jnnp-2022-ehdn.67
dc.identifier.endpageA24
dc.identifier.issn0022-3050
dc.identifier.issn1468-330X
dc.identifier.scopusqualityQ1
dc.identifier.startpageA24
dc.identifier.urihttps://doi.org/10.1136/jnnp-2022-ehdn.67
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10079
dc.identifier.volume93
dc.identifier.wosWOS:000891077600068
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.ispartofJournal of Neurology Neurosurgery and Psychiatry
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleMIR-122 DYSREGULATION IN SIRNA-TREATED IN VITRO CELL MODEL OF HUNTINGTON'S DISEASE
dc.typeConference Object

Dosyalar